Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study

Obesity is associated with differences in satiety, gastric emptying (GE), gastric volume, and psychological traits. Exenatide, a short-acting glucagon-like peptide 1 (GLP-1) receptor agonist, is associated with variable weight loss. We compared the effects of exenatide, 5 μg, and placebo SQ, twice d...

Descripción completa

Detalles Bibliográficos
Autores principales: Acosta, Andres, Camilleri, Michael, Burton, Duane, O’Neill, Jessica, Eckert, Deborah, Carlson, Paula, Zinsmeister, Alan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632965/
https://www.ncbi.nlm.nih.gov/pubmed/26542264
http://dx.doi.org/10.14814/phy2.12610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632965/
https://www.ncbi.nlm.nih.gov/pubmed/26542264
http://dx.doi.org/10.14814/phy2.12610

Ejemplares similares